In accordance with all the privacy and security regulations, we're going to analyze that data. We're going to make it publicly available to everybody to be able to analyze with us. If it shows promise, we will expand access to these products to even more conditions amongst Medicare and Medicaid beneficiaries. I want to thank not just the Secretary, but Marty Makary. We want a lot of companies who are doing this research that approach the FDA for formal approval. (10:30–10:38)
CLAIM
Asserts that CMS may expand CBD access if data shows promise.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
